Tag: Heparin

Neutral effect of P2Y12 inhibitors in non-critical COVID-19 hospitalisations

Presented By
Prof. Jeffrey Berger, New York University Langone, USA
Trial
ACTIV-4A
Conference
AHA 2021
Type
Peer-reviewed article

14 January 2022 16:30

COVID-19: Thromboembolic risk reduction with therapeutic heparin dosing

Presented By
Prof. Alex Spyropoulos, Northwell Health, USA
Trial
Phase 3, HEP-COVID
Conference
ESC 2021
Type
Peer-reviewed article

26 October 2021 16:34
site created by:   

© 2024 Medicom Medical Publishers.  All rights reserved. Terms and Conditions | Privacy Policy



HEAD OFFICE
Laarderhoogtweg 25
1101 EB Amsterdam
The Netherlands
T: +31 85 4012 560
E: publishers@medicom-publishers.com